# Thermopylae Capital Grants 435,000 Options to Officers and Advisors at $0.10

> Thermopylae Capital granted 435,000 fully vested options at $0.10 per share to senior officers and advisors, subject to TSXV acceptance and escrow.

- Published: 2026-10-16T01:35:19+00:00
- Section: Leadership
- Author: News Desk
- URL: https://newsforagent.com/news/2026-10-16/thermopylae-capital-stock-options-grant
- Source: [Aktien](https://www.wallstreet-online.de/nachricht/21533326-thermopylae-capital-inc-announces-grant-of-stock-options)

## Key takeaways

- Thermopylae Capital's board approved 435,000 fully vested stock options for senior officers and advisors.
- The options carry an exercise price of $0.10 per share and expire on October 15, 2031.
- The grant is subject to TSXV acceptance and the options will be deposited in escrow.
- Thermopylae Capital raised CAD $333,000 in its March 2026 IPO and has no assets other than cash.

[Thermopylae Capital](https://akta.pro/company-profiles/00pyopf/thermopylae-capital) Inc. granted 435,000 fully vested stock options to senior officers and advisors, exercisable at $0.10 per share until October 15, 2031, the company said. The board of directors approved the grant, which is subject to TSXV acceptance and escrow, according to [Aktien](https://www.wallstreet-online.de/nachricht/21533326-thermopylae-capital-inc-announces-grant-of-stock-options).

## Thermopylae Capital's Option Grant Terms

The options were granted under the company's stock option plan and are subject to the terms of the applicable grant agreements and TSXV requirements. Each option entitles the holder to acquire one common share at an exercise price of $0.10 at any time until October 15, 2031. The options are fully vested and will be deposited in escrow under an escrow agreement.

Thermopylae Capital is a capital pool company under TSXV Policy 2.4. The company has not commenced commercial operations and has no assets other than cash. Until it completes a qualifying transaction, it will not carry on business other than identifying and evaluating businesses or assets.

Bill Mavridis, a director and investor relations contact, is named in the announcement. The company's leadership includes Dr. Ken (Kyriakos) Matziorinis as CEO and director, Nicholas (Nick) Demos as president, Véronique Laberge as CFO and director, and Vasilios (Bill) Mavridis as director and investor relations, according to [company records](https://akta.pro/company-data).

## Thermopylae Capital's IPO and Share Count

Thermopylae Capital completed its initial public offering on the TSX Venture Exchange in March 2026, raising gross proceeds of CAD $333,000 through the issuance of 3,330,000 common shares at $0.10 per share, with Leede Financial Inc. as agent, according to akta.pro company records. The company received conditional TSXV listing approval and commenced trading under the symbol THY.P on March 23, 2026. Following the IPO, 6,130,000 shares were issued and outstanding.

A founder, Nicholas Demos, filed an early warning report disclosing a pre-IPO 75% stake and a post-IPO 34.26% non-diluted and 34.68% partially diluted ownership position in connection with the offering closing, the same records show.

## Thermopylae Capital's Next Steps

The options remain subject to TSXV acceptance and will be deposited in escrow. The company continues to await a qualifying transaction.

## Companies in this story

- [Thermopylae Capital company profile](https://akta.pro/company-profiles/00pyopf/thermopylae-capital) · website: https://www.thermopylaecapital.com

---
News for Agent · https://newsforagent.com/llms.txt